Gender specific association of genetic variation in peroxisome proliferator-activated receptor (PPAR)γ-2 with longevity

被引:51
作者
Barbieri, M
Bonafè, M
Rizzo, MR
Ragno, E
Olivieri, F
Marchegiani, F
Franceschi, C
Paolisso, G
机构
[1] Univ Naples 2, Dept Geriatr Med & Metab Dis, Div Med Interna 6, I-80138 Naples, Italy
[2] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy
关键词
PPAR gamma; Pro12Ala gene polymorphism; human longevity; ageing body composition;
D O I
10.1016/j.exger.2004.03.034
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Long-lived subjects have been shown to have peculiar anthropometric features (i.e. lower body mass index(BMI)) and metabolic parameters (i.e. improved insulin sensitivity). Life style and a genetic background potentially protective against the age-related metabolic derangement might contribute to such a particular phenotype. Peroxisome proliferator-activated receptor (PPAR)gamma-2 is an important regulator of adipose tissue metabolism, insulin sensitivity and inflammatory response. Thus, the potential role of genetic variability at Pro/Ala loci of PPARG gene on longevity was studied in 222 long-lived subjects and 250 aged subjects. We found a different Pro/Ala genotype frequency distribution between long-lived and aged men subjects, long-lived men having an increased frequency of Pro/Ala genotype (20 vs 8.5%); no differences was found when allele and genotype distribution of Pro/Ala gene polymorphism were analyzed in the two age group of women. Interestingly, subjects with Pro/Ala polymorphism had significantly lower BMI than Ala/Ala and Pro/Pro polymorphism. In conclusion, our study demonstrated that paraoxonase Pro/Ala gene polyporphism is associated with human longevity. Such an effect is probably due to the effect of Pro/Ala polymorphism on body composition and appears to be gender specific. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1095 / 1100
页数:6
相关论文
共 53 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [4] Altukhov YP, 2000, DOKL AKAD NAUK+, V370, P130
  • [5] Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene
    Beamer, BA
    Negri, C
    Yen, CJ
    Gavrilova, O
    Rumberger, JM
    Durcan, MJ
    Yarnall, DP
    Hawkins, AL
    Griffin, CA
    Burns, DK
    Roth, J
    Reitman, M
    Shuldiner, AR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) : 756 - 759
  • [6] Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
    Beamer, BA
    Yen, CJ
    Andersen, BE
    Muller, D
    Elahi, D
    Cheskin, LJ
    Andres, R
    Roth, J
    Shuldiner, AR
    [J]. DIABETES, 1998, 47 (11) : 1806 - 1808
  • [7] Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation
    Blanquart, C
    Barbier, O
    Fruchart, JC
    Staels, B
    Glineur, C
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) : 267 - 273
  • [8] Increase of homozygosity in centenarians revealed by a new inter-Alu PCR technique
    Bonafé, M
    Cardelli, M
    Marchegiani, F
    Cavallone, L
    Giovagnetti, S
    Olivieri, F
    Lisa, R
    Pieri, C
    Franceschi, C
    [J]. EXPERIMENTAL GERONTOLOGY, 2001, 36 (07) : 1063 - 1073
  • [9] Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.3.CO
  • [10] 2-O